Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127516 · ClinicalTrials.gov registry record
The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 45
- Enrollment target
NCT01127516: Completed study, sponsored by Virginia Commonwealth University.
NCT01127516 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01127516 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The hypothesis of this investigation is that rate of isolation of resistant nosocomial pathogens can be explained by a combination of measures that include, among other things, antimicrobial drug use, infection control efforts, patient mix and antimicrobial stewardship efforts. The short term goal of this investigation is to improve our understanding of the relationships between antimicrobial stewardship program efforts (and actual antimicrobial drug use), and infection control efforts to the incidence rates of MSSA, MRSA, h-VISA and SA-MICcreep. The long term goal of this investigation is to design interventions that will improve antimicrobial drug use and decrease cross-transmission of resistant bacteria, resulting in a decrease in the rates of infection caused resistant hospital organisms.
Primary Outcome
Survey of hospitals participating in the UHC consortium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-05 |
What the finished NCT01127516 record still lists
NCT01127516 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01127516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01127516 about?
NCT01127516 is a clinical study titled "The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus". The hypothesis of this investigation is that rate of isolation of resistant nosocomial pathogens can be explained by a combination of measures that include, among other things, antimicrobial drug use, infection control efforts, patient mix and antimicrobial stewardship efforts. The short term goal o...
What is the current status of trial NCT01127516?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2010-04. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01127516?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia